Advancing CPO screening: Integrating Molecular Techniques for Better Lab Practices and Diagnostic Stewardship

In the fast-paced world of healthcare-associated infections (HAIs) management, time is of the essence. Traditional diagnostic techniques, which can take days to yield results, often lead to challenges such as inefficient patient and bed management, increased isolation costs, and higher laboratory workloads. The growing threat of carbapenem-non-susceptible Gram-negative organisms, characterized by their high mortality rates and the potential for widespread transmission, further complicates the challenge. The KPC, VIM, NDM, OXA-48 and IMP carbapenemase genes are some of the most frequently identified that confer carbapenem resistance, but emerging genes, such as OXA-23, pose a challenge in diagnostic testing with the currently available methods.

 

Join us for an insightful webinar where two esteemed clinical microbiologists from Brazil and France will provide their perspectives and share their expertise on integrating molecular techniques for CPO (carbapenemase-producing organism) screening. Discover how these advanced methods can enhance diagnostic stewardship efforts within antimicrobial stewardship programs, streamline lab practices, and improve patient management.

 

Learning Objectives